Elevated transcranial Doppler ultrasound velocities following therapeutic arterial dilation

Propofol/Remifentanil Anesthesia Might Not Alter the Middle Cerebral Artery Diameter by Digital Subtraction Angiography

INTRODUCTION

Transcranial Doppler (TCD) of the middle cerebral artery (MCA) enables the measurement of the mean blood velocity (MCA_Vm) and the estimation of the cerebral blood flow (CBF), provided that no significant changes occur in the MCA diameter (MCA_Diam). Previous studies described a decrease in the MCA_Vm associated with the induction of total intravenous anesthesia (TIVA) by propofol and remifentanil. This decrease in blood velocity might be interpreted as a decrease in the CBF only where the MCA_Diam is not modified across TCD examinations.

METHODS

In this observational study, we measured the MCA_Diam of 24 subjects (almost exclusively females) on digital subtraction angiography under awake and TIVA conditions.

RESULTS

Across the two phases, we observed a decrease in the mean arterial blood pressure (from 84 ± 9 to 71 ± 6 mmHg; p < 0.001) and heart rate (76 ± 10 vs. 65 ± 8 beats/min; p < 0.001), and a concomitant decrease in the MCA_Vm (61 vs. 42 cm/s; p < 0.001). In contrast, the MCA_Diam did not vary in association with TIVA (2.3 ± 0.2 vs. 2.3 ± 0.2 mm; p = 0.52).

CONCLUSIONS

Those results suggested that in this population, no significant changes in the MCA_Diam are associated with TIVA.

Advances in transcranial Doppler clinical applications

IMPORTANCE OF THE FIELD

Diagnostic neurosonology techniques including transcranial Doppler (TCD), transcranial color Doppler imaging (TCDI) and power motion-mode (PMD) TCD provide information about various aspects of cerebrovascular status such as microemboli detection, dynamic autoregulation and long-duration real-time monitoring of flow characteristics. Although most of the information provided cannot be obtained by any other imaging methodology, and is critical in clinical decision-making in the care of various neurovascular diseases, these modalities are widely underutilized. Increasing the familiarity to neurosonological techniques is of crucial importance.

AREAS COVERED IN THIS REVIEW

After briefly reviewing TCD, TCDI and PMD techniques, classical features are summarized and recent developments in the clinical neurosonology applications with specific interest in the neurovascular disorders.

WHAT THE READER WILL GAIN

Practical perspectives of ultrasound evaluation of intracranial arterial status in various neurovascular diseases including sickle cell vasculopathy and vasospasm are reviewed in detail. Pearls on the neurosonological monitoring of acute ischemic stroke and increased intracranial pressure increase is provided. Standards of cerebral microembolism detection, right to left shunts diagnosis and cerebral autoregulation assessment are discussed methodologically. Future perspectives of therapeutic neurosonology including sonothrombolysis, microbubble-ultrasound-mediated gene and drug delivery into the brain, and alteration of the brain-blood barrier permeability are summarized.

TAKE HOME MESSAGE

Suitable with future medicine, neurosonology brings imaging to the bedside, which enables the treating physician to monitor a given intervention in real time. A non-invasive neurosonology-guided treatment of various diseases could be possible in the near future. The first and foremost step in gaining mastery in this very fruitful field is beginning to use it.

Applications of transcranial Doppler in the ICU: a review

OBJECTIVE

Transcranial Doppler (TCD) ultrasonography is a technique that uses a hand-held Doppler transducer (placed on the surface of the cranial skin) to measure the velocity and pulsatility of blood flow within the intracranial and the extracranial arteries. This review critically evaluates the evidence for the use of TCD in the critical care population.

DISCUSSION

TCD has been frequently employed for the clinical evaluation of cerebral vasospasm following subarachnoid haemorrhage (SAH). To a lesser degree, TCD has also been used to evaluate cerebral autoregulatory capacity, monitor cerebral circulation during cardiopulmonary bypass and carotid endarterectomies and to diagnose brain death. Technological advances such as M mode, colour Doppler and three-dimensional power Doppler ultrasonography have extended the scope of TCD to include other non-critical care applications including assessment of cerebral emboli, functional TCD and the management of sickle cell disease.

CONCLUSIONS

Despite publications suggesting concordance between TCD velocity measurements and cerebral blood flow there are few randomized controlled studies demonstrating an improved outcome with the use of TCD monitoring in neurocritical care. Newer developments in this technology include venous Doppler, functional Doppler and use of ultrasound contrast agents.

[Monitoring jugular venous oxygen saturation in severe cerebral vasospasm after subarachnoid hemorrhage]

Cerebral arterial vasospasm is a major complication of aneurysmal subarachnoid haemorrhage. The conventional treatment of this complication includes haemodilution, hypervolaemia, arterial hypertension and nimodipine. Some patients do not respond to this therapy and require an intraarterial infusion of papaverine and/or a cerebral angioplasty. Transcranial Doppler detects cerebral vasospasm. However it does not provide an accurate metabolic information on the ischaemic status of the cerebral tissue. This article describes the monitoring of jugular venous bulb oxygen saturation to obtain a real time information on the metabolic effect of cerebral vasospasm and its variations after intra-arterial infusion of papaverine.

Estimation of vessel flow and diameter during cerebral vasospasm using transcranial Doppler indices

OBJECTIVE

An important limitation of transcranial Doppler (TCD) ultrasonography is its inability to directly measure blood flow or vessel diameter. To extend the ability of TCD ultrasonography, indices were derived from an intensity-weighted mean of the entire Doppler spectrum. The objective of this article is to test the behavior of these indices under conditions of diameter constancy (hyper- and hypoventilation) and when vessel diameter decreases (vasospasm).

METHODS

A flow index (FI) was calculated by averaging several heartbeats of spectral data and calculating the first spectral moment. An area index (AI) was defined as the FI divided by the mean velocity, motivated by the knowledge that vessel flow is the product of vessel diameter and mean velocity. To test the FI and the AI under conditions of diameter constancy, middle cerebral artery Doppler signals were obtained from 20 patients during conditions of hypercarbia, hypocarbia, and normocarbia. To test the ability of these indices to evaluate a decrease in vessel diameter, signals from 41 sites on 23 arteries were obtained from patients who underwent both TCD and angiographic studies on two separate occasions after the occurrence of subarachnoid hemorrhage. The changes in the AI were compared with the arterial diameters measured from angiograms.

RESULTS

The FI was proportional to the mean velocity in the cohort of healthy patients (r=0.97). The AI changed by less than 3% in the same cohort. The AI predicted the direction of the diameter change in all vessels showing angiographic changes in area. Changes in the AI and the measured angiographic changes in cross-sectional areas were correlated (overall, r=0.90; with two outlines removed, r=0.86).

CONCLUSION

This variant of the intensity-weighted mean predicts changes in vessel cross-sectional area under conditions of changes in CO2 and cerebral vasospasm. This preliminary study suggests that careful use of this tool may provide accurate evaluation of cerebral blood flow through the large vessels and quantitative changes in diameter, which occur frequently after subarachnoid hemorrhage.

Transcranial Doppler ultrasonography in the neurocritical care unit

TCD ultrasonography is a noninvasive means to study the cerebral vasculature. By varying the depth and angle of insonation of a pulsed sound wave, the direction and velocity profile of the cerebral arteries can be ascertained. This can be used to identify areas of focal stenosis and increased resistance and to estimate the adequacy of cerebral flow. TCD ultrasonography commonly is used in SAH to detect cerebral vasospasm. Many centers interpret rising velocities as increasing vessel narrowing and initiate medical strategies based on these values. TCD use in head trauma is less clearly defined. TCD ultrasonography is considered an acceptable confirmatory test for the determination of brain death. TCD ultrasonography is capable of studying dynamic cerebrovascular processes. By being able to determine vessel patency, TCD may become a useful adjuvant to thrombolytic therapy. Continuous monitoring of flow velocities and profiles along with testing to cerebrovascular reserve promises to be a future active area of research.

Superselective intraarterial papaverine administration: effect on regional cerebral blood flow in patients with arteriovenous malformations

In this study the authors determined the effect of papaverine on regional cerebral blood flow (rCBF) in the angiographically normal arteriolar beds of patients with arteriovenous malformations (AVMs) who underwent transfemoral superselective angiography. Middle cerebral artery (MCA) branch vessels were catheterized during 10 procedures performed in nine patients. The mean (+/- standard deviation) largest AVM diameter was 4.4 +/- 1 cm. Regional CBF was measured by recording the washout of a bolus of xenon-133 injected through the microcatheter. In a dose-ranging study. rCBF and MCA pressure in two patients were repeatedly measured after 3-minute infusions of papaverine at 0.07, 0.7, and 7 mg/minute. In a single-dose study, an additional eight patients received only the highest dose of papaverine administered over a 3-minute period. In the dose-ranging study, CBF increased from baseline in a dose-dependent fashion. In the single-dose study, papaverine increased in rCBF 103%, from 48 +/- 11 to 95 +/- 23 ml/100 g/minute at an MCA pressure of 55 +/- 23 mm Hg. Increase in rCBF was linearly related (y = 2.2x - 17, r2 = 0.84; p = 0.001) to baseline MCA pressure (range 22-84 mm Hg). Papaverine increases rCBF in a direct proportion to baseline MCA pressure, even at low baseline pressures. Selective infusion of vasodilators should be investigated in acute cerebral hypotension to facilitate either primary or collateral recruitment of CBF by aiding spontaneous autoregulatory vasodilation. In addition, rCBF monitoring may be useful in determining the most effective intraarterial dose of papaverine while minimizing complications due to hyperemia.